Navigation Links
Need More And Better Drugs To Tackle Stoke

Stroke is one of the common causes of death among the Americans. Nearly 500000 people suffer the first stroke and 200000 suffer from recurrent attack of stroke. Though it has been a major cause of death doctors are prescribing the same drug that was discovered ten years ago. //There has not been any new significant study on the treatment of stroke patients.

Thee dug activase was the drug that created a major break through in the treatment of stroke and is still the only drug available. This drug is produced by the biotech firm, Genentech and is available only for a small number of patients.

Mark Alberts of Northwestern University in Chicago says that this drug is used only by 3-4% of the patients. But now after creating a lot awareness among the people the scenario is changing for the better.

Activase (tissue plasminogen activator or tPA) sales are on the rise. Statistics published in the February issue of the journal Neurology found that the dug was used by 17000 patients. The use of Activase doubled in the 11 centers of stroke treatment. Vanja Douglas of the University of California-San Francisco and her colleagues said that in one particular center the use of activase jumped from 1.5% of patients to 10.5%.

The government is also taking all possible measures to increase the use of activase among the stroke patients. It has issued a ruling that U.S. Center for Medicare and Medicaid Services pay all the hospitals $11,578, who treat stroke patients with Activase, which is double the amount they were paid previously.

Joseph Broderick, neurologist at the University of Cincinnati said that a lot of other researches are in the pipeline to protect the people from Stroke. Stoke is mainly due to the complete blocking of the blood supply to the brain. This can arise when the clot obstructs the passage of the artery. About 85% of the strokes cases are due to the arterial blocks that supply blood along with nutrients
'"/>




Page: 1 2 3

Related medicine news :

1. Better prostate cancer detection
2. Better Treatment for obesity
3. For a Better Memory
4. Baby Talk Better Than Adult Speech
5. Drug Combo Works Better for children with ADHD, Tics
6. Better skin with lasers
7. Better diabetes treatment promises Vanadium
8. Better Prostate Cancer Test
9. Better Drug for Heart Transplant
10. Better Diet Even Late in Life May Prolong It
11. Better Care Required for Breast Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Need More And Better Drugs Tackle Stoke

(Date:10/7/2008)...GTON, Oct. 7 /PRNewswire-USNewswire/ -- Kristi Yam...er of Dancing With the Stars, has been,named chair...stmas Seals,Campaign in an effort to help raise fu...revent lung disease and promote lung health., The...on began in 1907,to conquer Tuberculosis. Today, t...
(Date:10/7/2008)...n ultrasound similar to more expensive whole-leg c...ESDAY, Oct. 7 (HealthDay News) -- An older, simple...d deep vein thrombosis, or DVT -- is as effective .... , European researchers found that 2-point ult...ssion or duplex ultrasound -- was as good at detec...
(Date:10/7/2008)...ILLE, Fla. Based on results of a landmark study, ...future in which virtual biopsies will eliminate th...us or will not morph into the disease. , Curren...ring colonoscopies end up being harmless, but they...reases time, expense and the potential for complic...
(Date:10/7/2008)... introduces Color Me Healthy(TM)/Salud Primero to ...urriculum, BENSENVILLE, Ill., Oct. 7 /PRNewswire/...an expansive campaign to bring a comprehensive die...t and Early Head Start,classrooms in an effort to ...ty and diabetes in minority children. Lifelink als...
Breaking Medicine News(10 mins):Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3Health News:Mayo Clinic estimates new, tiny, super-sensitive probe could cut colon polyp removal in half 2Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 2Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 3
...ychopharmacology held its annual meeting at Nashvi...n and behavior researchers called for// the need t...ychotropic drugs to treat mental illness. The pan... academics, industry and government. They held sev...
...inator, explained how India’s legal stance on homo...ht against HIV/AIDS and is an// infringement of th...orced mainly to bring offenders to book, in cases ... There is also fear that if the law is annulled, i...
...d a spray-on condom which will be suitable for all...or Condom Consultancy, said "We're trying to devel...very size of penis. We're very serious." The team...spray ‘can’ to exactly fit a man's penis. It is de...
... most favoured destinations for collaborative R&D,...ing and clinical research as a result of// growing...rds such as Good Laboratory Practices, current Goo...al Practices and patent laws. As per the current ...
Other Medicine News:Health News:Research In A New Direction To Develop Innovative Psychotropic Drugs 2Health News:Research In A New Direction To Develop Innovative Psychotropic Drugs 3
(Date:10/6/2008)...wire-FirstCall/ -- Pharmasset, Inc.,(Nasdaq: VRUS...ining the,Company as Vice President of Investor Re...ll be responsible for all investor relations,funct...fficer Kurt,Leutzinger., Most recently, Dr. Smith...lyst at JPMorgan Securities, and has been an analy...
(Date:10/6/2008)...wswire/ -- "A return to the use of,chimpanzees in ...cientific,justification," according to a paper rel...ory Animals (ATLA). "An Assessment of the Role of,...at vaccine responses in,chimpanzees are not predic...impanzees, critical role and importance in AIDS va...
(Date:10/6/2008)...Annual Scientific Conference -, ORLANDO, Fla., Oc...merly Microbia) today announced presentation of da...the role that cyclic guanosine,monophosphate (cGMP...ies,demonstrate that cGMP inhibits intestinal pain... and desensitizes colonic afferent nerves in a,sim...
(Date:10/6/2008)...llaborate to Improve Patient Safety, WASHINGTON, ...lege of,Cardiology in collaboration with the Ameri...eart Association today released consensus guidelin...risk of ulcers and,gastrointestinal (GI) bleeding ...y drugs (NSAIDs) along with antiplatelet agents., ...
Breaking Medicine Technology:Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4Vangent Inc Awarded Contract to Support Military Health Systems Executive Information and Decision Support Program 3837 1Vangent Inc Awarded Contract to Support Military Health Systems Executive Information and Decision Support Program 3837 2Science Magazine Recognizes Monsanto as Top Employer 1297 1Science Magazine Recognizes Monsanto as Top Employer 1297 2Mans Best Friend May Open Door to Understanding Fibrotic Lung Disease in Human and Animal Populations 537 1Mans Best Friend May Open Door to Understanding Fibrotic Lung Disease in Human and Animal Populations 537 2Mans Best Friend May Open Door to Understanding Fibrotic Lung Disease in Human and Animal Populations 537 3Mans Best Friend May Open Door to Understanding Fibrotic Lung Disease in Human and Animal Populations 537 4Mans Best Friend May Open Door to Understanding Fibrotic Lung Disease in Human and Animal Populations 537 5UF researchers track genetic journey of HIV from birth to death 3834 1UF researchers track genetic journey of HIV from birth to death 3834 2UF researchers track genetic journey of HIV from birth to death 3834 3
...es support the development of DG041 as an,effectiv...sk, REYKJAVIK, Iceland, June 25, 2007 /PRNewswire-...ress in the development of,DG041, the company,s Ph...f arterial thrombosis. The results of the Phase II...y build upon previous,findings demonstrating DG041...
...Statistically Significant Clinical Results for,SB-...pathy, CHICAGO, June 22, 2007 /PRNewswire-FirstCal...e presentation of encouraging,Phase 1 clinical dat... Scientific Sessions of the American Diabetes Asso...n entitled, "Improved,Neurologic Exam and Nerve Co...
Other Medicine Technology:Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 2Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 3Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 4Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 5Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 6Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 2Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 3Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 4Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 5Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 6Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 7Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 8Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 9
The 6303 is an affordable path to Sonesta flexibility. Three motors provide full height, seat, and back adjustments. Packaged with basic accessories, the 6303 accepts the full line of Sonesta add-ons
For complete unobstructed imaging coverage for a wide range of urological procedures, HealthTronics urodynamics Chair/Table is the answer.
The Advanced Model BR2 Bilirubin STAT-Analyzer® provides a rapid, accurate determination of total and direct bilirubin in neonates. And because it's so compact and easy to use, it is appropriate
...e utilises a generic PCR amplification with biotin...on of an HLA locus. This is followed by hybridisat...nce Specific Oligonucleotide probes immobilised on...bes is referred to as a Reverse Line blot and thus...
Medicine Products: